Novartis
Traded as NYSE: NVS
Industry Drug Manufacturers – Major
Founded 1996
Headquarters Basel 4056, Switzerland
CEO
Mr. Joseph Jimenez
Revenue US$ 50.387 billion
Operating income
US$ 8.977 billion
Net income
US$ 17.794 billion
Total assets US$ 131.556 billion
Total equity US$ 77.046 billion
Number of employees
118.000
Website Novartis.com
Source
Novartis.com/news/annual-report-2015

About:

 

Novartis AG,

is a biotechnology and pharmaceutical company based in Basel, Switzerland. The company was created in 1996 from the merger of “Ciba-Geigy AG” and “Sandoz”. Novartis goes back to several Basler tar-colour producers who joined together over the time to Novartis. Today, Novartis is the world’s largest pharmaceutical company and has, under the current CEO Joseph Jimenez, 118000 employees and a revenue of 50.387 billion USD.

Operation divisions: Pharmaceuticals (Consumer health and animal health)

Since 1996, Novartis has engaged in a number of M&A deals: 106 transactions with a value of  USD 107.83 bil. (for number and value per year, see figure below).

M&A Novartis

Top 10 Deals Novartis

RankDateTargetNationValue (in bil. USD)Status
104.07.2008Alcon IncSwitzerland27.73Completed
204.22.2014GlaxoSmithKline PLC OncologyUnited Kingdom16.00Completed
301.04.2010Alcon IncSwitzerland12.14Completed
404.07.2008Alcon IncSwitzerland10.55Completed
509.01.2005Chiron CorpUnited States6.21Completed
602.21.2005Hexal AGGermany5.68Completed
712.02.1999AstraZeneca PLC AgrochemicalsSwitzerland5.06Completed
805.07.2001Roche Holding AGSwitzerland2.79Completed
912.31.2002Roche Holding AGSwitzerland2.58Completed
1001.21.1998Allied Colloids Group PLCUnited Kingdom2.31Completed